Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
IOVANCE BIOTHERAPEUTICS, INC.
Last earnings -13.2% on 2026-05-07
Revenue grew 60.6% YoY; but unprofitable (net margin -148.4%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
IOVANCE BIOTHERAPEUTICS, INC. shows $264M in FY2025 revenue (+60.6% YoY), a -148.4% net margin, and -56.0% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001425205, latest 10-Q filed 2026-05-07) · EODHD · rules-based read · as of 6/18/2026, 3:56:33 AM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | $1.19M | $164M | $264M |
| Gross profit | — | — | — | — | — |
| Operating income | -$343M | -$399M | -$461M | -$395M | -$403M |
| Net income | -$342M | -$396M | -$444M | -$372M | -$391M |
| Diluted EPS | -$2.23 | -$2.49 | -$1.89 | -$1.28 | -$1.09 |
| Net margin | — | — | -37345.4% | -226.8% | -148.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
| 2026-06-05 | Vogt Frederick G Interim CEO & General Counsel | Exercise | 15.6K | |
| 2026-06-05 | Vogt Frederick G Interim CEO & General Counsel | Tax | 6.64K @ $4.23 | $28.1K |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Exercise | 7.81K | |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Tax | 3.98K @ $4.23 | $16.8K |
| 2026-06-05 | Puri Raj K. Chief Regulatory Officer | Exercise | 9.77K | |
| 2026-06-05 | Puri Raj K. Chief Regulatory Officer | Tax | 3.84K @ $4.23 | $16.3K |
| 2026-06-05 | BILINSKY IGOR Chief Operating Officer | Exercise | 7.81K | |
| 2026-06-05 | BILINSKY IGOR Chief Operating Officer | Tax | 3.98K @ $4.23 | $16.8K |
| 2026-06-01 | Vogt Frederick G Interim CEO & General Counsel | Exercise | 41.7K | |
| 2026-06-01 | Vogt Frederick G Interim CEO & General Counsel | Tax | 17.7K @ $3.96 | $70.1K |
| 2026-06-01 | Puri Raj K. Chief Regulatory Officer | Exercise | 5.47K | |
| 2026-06-01 | Puri Raj K. Chief Regulatory Officer | Tax | 2.51K @ $3.96 | $9.93K |